Sign in

lsoucek.bsky.social

@lsoucek.bsky.social
34 followers 2 following 24 posts
PostsRepliesMedia
lsoucek.bsky.social @lsoucek.bsky.social · 04/08/2026
Proud to see another publication from the @lsouceklab.bsky.social by Manuel Lillo and @marianozf.bsky.social in @frontiersin.bsky.social! 🎉 Read here how #MYC shapes #melanoma progression, plasticity and resistance: frontiersin.org/articles/10.33… @vhio.bsky.social @icreacommunity.bsky.social
frontiersin.org
000
lsoucek.bsky.social @lsoucek.bsky.social · 06/07/2026
One more PhD in the @lsouceklab.bsky.social! I could not be prouder of Íñigo González Larreategui. His PhD defense was a testament of how much he has grown as a scientist. Looking forward to his brilliant career 💫
000
lsoucek.bsky.social @lsoucek.bsky.social · 03/06/2026
For years, #RAS and #MYC were considered "undruggable." The success of RAS has changed the conversation. Proud to see this recent @nature.com News & Views highlighting MYC as a promising next frontier and #Peptomyc as a key player helping advance the field. www.nature.com/articles/d41...
nature.com
Landmark cancer trial shows success against ‘undruggable’ cancer — raising hopes for future treatments
Unprecedented results against a stubbornly hard-to-treat cancer are boosting optimism that other challenging tumours will be next.
032
lsoucek.bsky.social @lsoucek.bsky.social · 13/03/2026
Que suerte haber podido contar contigo, Erika, en mis primeros años organizando el nuevo lab en Barcelona. Siempre digo que no sé cómo lo hubiera hecho sin ti. Gracias por tu apoyo y buen humor. Ha sido un verdadero placer trabajar contigo. Te deseo toda la suerte del mundo!
001
lsoucek.bsky.social @lsoucek.bsky.social · 21/02/2026
Gracias a @manuelansede.bsky.social y a @elpais.com. Solo quise recordar algo esencial: cuando están en juego esperanza y miedos de pacientes con cáncer, la información debe ser rigurosa, responsable y prudente. elpais.com/ciencia/2026...
elpais.com
El larguísimo trecho desde la ‘cura’ del cáncer en ratones hasta las personas
La científica Laura Soucek, que eliminó tumores en roedores hace casi 20 años, invoca el “deber moral” de no generar falsas expectativas tras el anuncio de Mariano Barbacid
093
lsoucek.bsky.social @lsoucek.bsky.social · 06/02/2026
Very proud to be one of the Catalan awardees of the @erc.europa.eu Proof of Concept grants. The grant #SonoMYC is built on the collaboration among @vhio.bsky.social, #Peptomyc and #Carthera. Grateful to the #ERC for supporting us and honoured to be in the company of extraordinary colleagues.
031
lsoucek.bsky.social @lsoucek.bsky.social · 23/01/2026
New review just out in Frontiers in Immunology! 🎉 We dive into how #MYC reshapes the tumor–immune interface to drive #immuneescape and resistance to #immunotherapy. Open access here 👉 www.frontiersin.org/journals/imm... @vhio.bsky.social @icreacommunity.bsky.social @lsouceklab.bsky.social #peptomyc
frontiersin.org
Frontiers | MYC at the tumor–immune interface: mechanisms of immune escape and immunotherapy resistance
Immunotherapies have transformed cancer treatment by harnessing the immune system to recognize and eliminate malignant cells, offering durable clinical benef...
020
lsoucek.bsky.social @lsoucek.bsky.social · 18/01/2026
Last week in San Francisco was intense, productive, and personally meaningful. As CSO of #Peptomyc, , I joined our CEO @jesusmartingarcia.bsky.social during #JPMHealthcare week to meet with pharmaceutical companies and discuss potential strategic collaborations. 📍 San Francisco
120
Reposted by @lsoucek.bsky.social
lsouceklab.bsky.social @lsouceklab.bsky.social · 11/01/2026
We are hiring! If you are interested in joining our Models of Cancer Therapy Laboratory lab at @vhio.bsky.social as a Research Laboratory Technician / Lab Manager, apply here: jobs.vhio.net/en/jobs/7018...
jobs.vhio.net
2026-002-01 Research Laboratory Technician / Lab Manager - VHIO
Under the leadership of Josep Tabernero, VHIO is an internationally recognized cancer center. Its multidisciplinary, collaborative model drives scientific progress and innovative cancer treatments.
022
lsoucek.bsky.social @lsoucek.bsky.social · 05/01/2026
Really happy to share our new open-access review in Frontiers in Cell and Developmental Biology 🎉 #MYC inhibition creates vulnerabilities that can be targeted with #DDR inhibitors. @vhio.bsky.social @icreacommunity.bsky.social #peptomyc @lsouceklab.bsky.social www.frontiersin.org/journals/cel...
frontiersin.org
Frontiers | The leading role of MYC in DNA damage response: exploring opportunities for therapeutic inhibition
MYC performs a dual role in DNA Damage Response (DDR), promoting genomic instability through replication stress, R-loop formation, and topoisomerase-mediated...
042
lsoucek.bsky.social @lsoucek.bsky.social · 04/12/2025
Honored to deliver a keynote today at the 19th Scientific Day & 29th Annual Conference of Vall d’Hebron on collaborative, challenge-driven research with transformative health impact. #MYC #OMO-103 #Omomyc @vhio.bsky.social @icreacommunity.bsky.social #peptomyc
062
lsoucek.bsky.social @lsoucek.bsky.social · 04/12/2025
Ayer, 3 de diciembre, participé como ponente en la XV edición del @cniostopcancer.bsky.social Lab Day, contando mi experiencia científica y emprendedora en @vhio.bsky.social, @icreacommunity.bsky.social y #Peptomyc. Muchas gracias a los estudiantes por invitarme! @msmelanoma.bsky.social
091
lsoucek.bsky.social @lsoucek.bsky.social · 03/12/2025
Our work MYC inhibition by Omomyc causes DNA damage and overcomes PARPi resistance in breast cancer has been accepted in @cp-cellreports.bsky.social : 🚀
142
lsoucek.bsky.social @lsoucek.bsky.social · 19/11/2025
Encantada de participar en el Ennova Health Day representando a @vhio.bsky.social, @icreacommunity.bsky.social y #Peptomyc. Gracias a la organización, #DiarioMédico y a los colegas de mesa por un debate inspirador. La innovación nace en y para el hospital.
021
lsoucek.bsky.social @lsoucek.bsky.social · 19/11/2025
Encantada de participar en el Ennova Health Day representando a @vhio.bsky.social, @icreacommunity.bsky.social y #Peptomyc. Gracias a la organización, #DiarioMédico y a los colegas de mesa por un debate inspirador. La innovación nace en y para el hospital.
020
lsoucek.bsky.social @lsoucek.bsky.social · 18/10/2025
Mil gracias a la @fundacionfero.bsky.social por su invitación a impartir una Charla Científica en el Circulo Ecuestre y contar el desarrollo de nuestra terapia para el tratamiento del cáncer. 🙏🏻 Gracias FERO por vuestro apoyo continuo a la investigación contra el cáncer! @vhio.bsky.social #peptomyc
053
lsoucek.bsky.social @lsoucek.bsky.social · 11/10/2025
Este lunes, a las 19:00, tendré el placer de dar una charla para la @fundacionfero.bsky.social en el Círculo Ecuestre en Barcelona , contando el viaje que recorrió nuestro fármaco desde el laboratorio hasta los ensayos clínicos. Para registrarte: administracion@circuloecuestre.es
022
lsoucek.bsky.social @lsoucek.bsky.social · 20/08/2025
Honored to give the closing talk at the inaugural #GordonResearchConference (#GRC) on #Microproteins tomorrow in Castelldefels, Spain. Excited to share our latest work on developing a clinically viable MYC inhibitor and wrap up an incredible week of cutting-edge science. @vhio.bsky.social #peptomyc
012
lsoucek.bsky.social @lsoucek.bsky.social · 19/02/2025
We are delighted to share that our review “MYC in cancer: from undruggable target to clinical trials” is finally out in Nature Reviews Drug Discovery. What an amazing journey this has been and still promises to be! Big thanks to co-author Jonathan Whitfield. @vhio.bsky.social rdcu.be/eawOK
rdcu.be
MYC in cancer: from undruggable target to clinical trials
Nature Reviews Drug Discovery - Oncogene MYC has been considered ‘undruggable’ for many decades. This Review provides an overview of the various strategies to inhibit MYC, focusing on...
052